Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 70 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8461149

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  2. US 8461163

    Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1

    Takeda Pharmaceutical Company Limited · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  3. US 8455688

    HDAC inhibitors

    Lixte Biotechnology, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  4. US 8455653

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  5. US 8455621

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  6. US 8455507

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  7. US 8455493

    Imidazopyrazine Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  8. US 8455497

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  9. US 8455652

    Inhibitors for the soluble epoxide hydrolase

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  10. US 8450532

    Compounds useful in the preparation of tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  11. US 8450341

    Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors

    Almirall, S.A. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  12. US 8449890

    Neprilysin inhibitors

    Theravance, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  13. US 8450332

    LIMK2 inhibitors, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  14. US 8450489

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted May 28, 2013 · Expires May 23, 2033

    granted

  15. US 8445681

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted May 21, 2013 · Expires May 16, 2033

    granted

  16. US 8445491

    Wnt protein signalling inhibitors

    The Board of Regents of the University of Texas System · Granted May 21, 2013 · Expires May 16, 2033

    granted

  17. US 8440679

    Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors

    Aurigene Discovery Technologies Limited · Granted May 14, 2013 · Expires May 9, 2033

    granted

  18. US 8440652

    MST1 kinase inhibitors and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted

  19. US 8440706

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted May 14, 2013 · Expires May 9, 2033

    granted

  20. US 8440667

    Imidazopyrazine Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted

  21. US 8436187

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted

  22. AU 2012205809

    Phenethylsulfone isoindoline derivatives as inhibitors of PDE 4 and/or cytokines

    CELGENE CORP [CH] · Granted May 2, 2013 · Expires Apr 27, 2033

    granted

  23. US 8431594

    Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  24. US 8426426

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.